FDA authorizes Pfizer/BioNTech COVID-19 vaccine boosters for 16- and 17-year-olds
Just as with adults, 16- and 17-year-olds are eligible to receive a booster dose six months after their second dose of the Pfizer/BioNTech vaccine. About 2.6 million US teens in th…
